Embryonic stem cell (ES cell)-derived cardiomyocyte transplantation into the infarcted myocardium

将胚胎干细胞(ES细胞)来源的心肌细胞移植到梗塞心肌中

基本信息

  • 批准号:
    13671401
  • 负责人:
  • 金额:
    $ 2.37万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

The purpose of this study was to investigate the survival of embryonic stem cell (ES cell)-derived cardiomyocytes transplanted into the infarcted myocardium.In in vitro study, undifferentiated mouse ES cells carrying the enhanced green fluorescent protein (EGFP) were cultured in hanging drops for 7 days and plated onto dishes, and then beating clusters were dissected and used for the following analyses and transplantation. These cells were identified as cardiomyocytes by reverse transcription-polymerase chain reaction of cardiac-specific genes, recording of action potential, and immunostaining of sarcomeric myosin staining. As a result of in vitro study, ES cell-derived cardiomyocytes were shown to have myosin light chain-2v and alpha-myosin heavy chain genes expression, action potential like one from a sinus nodal cell and a ventricular myocyte, and positive for sarcomeric myosin staining.In in vivo study, a myocardial infarction rat model was made by the ligation of the left coronary artery. Beating clusters were injected into the border zone between the infarcted and normal myocardium. Ten and 30 days after transplantation EGFP expression, hematoxylin-eosin staining and immunostaining of sarcomeric myosin were investigated. As a result of in vivo study, EGFP-expressed cells were detected after transplantation, and a few of them were positive for sarcomeric myosin. No lymphocytic infiltration was observed.These results suggested that ES cells differentiated into cardiomyocytes in vitro and ES cell-derived cardiomyocytes could be transplanted into the infarcted myocardium and survive in vivo.
为探讨胚胎干细胞(embryonic stem cell,ES cell)来源的心肌细胞移植到梗死心肌后的存活情况,将携带增强型绿色荧光蛋白(enhanced green fluorescent protein,EGFP)的未分化小鼠ES细胞悬滴培养7 d后接种于培养皿上,分离搏动的细胞团,用于后续分析和移植。通过逆转录-聚合酶链反应检测心肌特异性基因、记录动作电位和肌节肌球蛋白免疫染色鉴定这些细胞为心肌细胞。体外研究的结果显示,ES细胞来源的心肌细胞具有肌球蛋白轻链-2v和α-肌球蛋白重链基因表达,动作电位类似于来自窦房结细胞和心室肌细胞的动作电位,并且肌节肌球蛋白染色阳性。将搏动簇注射到梗死和正常心肌之间的边界区。移植后10天和30天,观察肌节肌球蛋白的苏木精-伊红染色和免疫组化染色。作为体内研究的结果,移植后检测到EGFP表达的细胞,并且其中一些细胞对肌节肌球蛋白呈阳性。这些结果表明,ES细胞在体外可分化为心肌细胞,ES细胞源性心肌细胞可移植到梗死心肌中并在体内存活。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

TANIGUCHI Shigeki其他文献

TANIGUCHI Shigeki的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('TANIGUCHI Shigeki', 18)}}的其他基金

Hydrogen sulfide protects insulin-secreting cells from cell damage-Characterization of the cytoprotective effects and the molecular mechanisms-
硫化氢保护胰岛素分泌细胞免受细胞损伤-细胞保护作用和分子机制的表征-
  • 批准号:
    22790255
  • 财政年份:
    2010
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Construction of 3D cardiac tissue: alignment and maturation of cells, and improvement of contraction force by extensional stimulation
3D 心脏组织的构建:细胞的排列和成熟,以及通过拉伸刺激改善收缩力
  • 批准号:
    22591552
  • 财政年份:
    2010
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New therapy for heart failure: Engineered heart tissue toward to clinical use
心力衰竭的新疗法:工程心脏组织走向临床应用
  • 批准号:
    19591642
  • 财政年份:
    2007
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The studies of the functional significance of regenerating gene (Reg) in failing hearts.
再生基因(Reg)在衰竭心脏中的功能意义的研究。
  • 批准号:
    16591405
  • 财政年份:
    2004
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Xenotransplantation of ex vivo gene trandected cardiomyocytes
离体基因转染心肌细胞的异种移植
  • 批准号:
    11470277
  • 财政年份:
    1999
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Attempt at creating donor pig by nuclear transplantation for xenotrasplantation
异种移植用核移植培育供体猪的尝试
  • 批准号:
    09671389
  • 财政年份:
    1997
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

基于NLRP3/IL-1β信号探讨α7nAChR介导巨噬细胞—心肌细胞互作在Aβ诱导房颤心房重构中的作用及机制研究
  • 批准号:
    82300356
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
肌特异性miR-499在心肌细胞增殖和凋亡中作用的研究
  • 批准号:
    81070112
  • 批准年份:
    2010
  • 资助金额:
    10.0 万元
  • 项目类别:
    面上项目

相似海外基金

Smart drug evaluation system for matured engineered cardiomyocyte tissue
成熟工程化心肌细胞组织智能药物评价系统
  • 批准号:
    23H01382
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Supply and Demand: Oxygen and Workload Regulate Cardiomyocyte Proliferation
供需:氧气和工作量调节心肌细胞增殖
  • 批准号:
    10572541
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Label-free single-cell imaging for quality control of cardiomyocyte biomanufacturing
用于心肌细胞生物制造质量控制的无标记单细胞成像
  • 批准号:
    10675976
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Virtual drug screen reveals context-dependent inhibition of cardiomyocyte hypertrophy
虚拟药物筛选揭示了心肌细胞肥大的情境依赖性抑制
  • 批准号:
    10678351
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
A role for cardiomyocyte pannexin 1 in non-ischemic heart failure
心肌细胞pannexin 1在非缺血性心力衰竭中的作用
  • 批准号:
    10680109
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Immune Response-Mediated Regulation of Cardiomyocyte Growth and Renewal
免疫反应介导的心肌细胞生长和更新调节
  • 批准号:
    10625948
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Modulators of cardiomyocyte structure to promote functional recovery during cardiac regeneration and repair
心肌细胞结构调节剂促进心脏再生和修复过程中的功能恢复
  • 批准号:
    10751640
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Mechanisms of cardiomyocyte dysfunction in pediatric septic shock
小儿感染性休克心肌细胞功能障碍的机制
  • 批准号:
    10580624
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Ethnically Diverse iPSC-Cardiomyocyte Panel for Pharmacogenomics and Drug Safety Testing
用于药物基因组学和药物安全性测试的种族多样化 iPSC-心肌细胞小组
  • 批准号:
    10755624
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
Regulation of cardiomyocyte proliferation by the Reptin ATPase
Reptin ATP酶对心肌细胞增殖的调节
  • 批准号:
    10747229
  • 财政年份:
    2023
  • 资助金额:
    $ 2.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了